News

GPs warned not to fund translators

10-Apr-07

Practices that fund translation services previously paid for by primary care organisations weaken the argument that it is non-core work, according to Londonwide LMCs.

It gives the warning in guidance issued after GP revealed that Brent PCT in north-west London was to withdraw funding for interpreters and translators in GP practices (PCT to axe GP funding for translators - GP, 2 March 2007).

Dr Stewart Drage, joint chief executive of Londonwide LMCs, wrote to Brent practices and all London LMCs after Brent PCT withdrew funding for these services this month.

Dr Drage wrote the PCT maintained that responsibility for both providing and funding these services had transferred to practices.

'This concept of "transferring funding responsibility" which the PCT has dreamt up will be of great concern to all practices, because the PCT could try to do this for anything it chooses, not just language services,' he added.

Expert legal advice obtained by Londonwide LMCs contradicts the PCT's claim.

Dr Drage added: 'If you decide to fund and provide these yourself, you should be aware that this could be deemed as becoming part of essential services, and therefore you could be allowing the funding of these services to become a requirement for all practices in the UK.'

Comments

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Latest Clinical Articles

Hypothyroidism

Contributed by Dr Sudesna Chatterjee, consultant physician and specialist in diabetes and endocrinol... Read more

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

MIMS Product News

Valdoxan

Servier has launched Valdoxan (agomelatine) for the treatment of major depressive episodes in adults... Read more

BuTrans in moderate chronic pain

BuTrans ( buprenorphine ) patches are now indicated in the management of non-malignant moderate c... Read more

Diovan for heart failure

The angiotensin II antagonist Diovan (valsartan) is now licensed for the treatment of symptomatic... Read more

Interaction between clopidogrel and PPIs

The EU Committee for Medicinal Products for Human Use (CHMP) has stated that the concomitant use of ... Read more

Glivec licence extension

The licence for Glivec (imatinib) has been extended to include its use as an adjuvant post-surger... Read more